Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 118, Issue , 2017, Pages 13-20

  Nielsen, Line Hagner ^a   Rades, Thomas ^b   Boyd, Ben ^c   Boisen, Anja ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Lipid self assembly; Micro devices; Oral drug delivery; Oral vaccine delivery; Particulates; Spray drying

Indexed keywords

DISOPYRAMIDE PHOSPHATE; EUDRAGIT; GLYCEROL OLEATE; OVALBUMIN; ACYLGLYCEROL; DEXTRAN; LIPID; WATER;

ANTIGEN PRESENTING CELL; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; HUMAN; NANOFABRICATION; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; SPRAY DRYING; STOMACH PH; TRANSMISSION ELECTRON MICROSCOPY; X RAY CRYSTALLOGRAPHY; ADMINISTRATION AND DOSAGE; CHEMISTRY; DELAYED RELEASE FORMULATION; DESICCATION; MICELLE; POWDER; PROCEDURES; SMALL ANGLE SCATTERING; X RAY DIFFRACTION;

DELAYED-ACTION PREPARATIONS; DESICCATION; DEXTRANS; DRUG DELIVERY SYSTEMS; GLYCERIDES; LIPIDS; MICELLES; OVALBUMIN; PARTICLE SIZE; POWDERS; SCATTERING, SMALL ANGLE; WATER; X-RAY DIFFRACTION;

EID: 85010807569     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2016.12.008     Document Type: Article

References (44)

1. Zhao, Z., Leong, K.W., Controlled delivery of antigens and adjuvants in vaccine development. J. Pharm. Sci. 85 (1996), 1261–1270, 10.1021/js9602812.
2. Stern, A.M., Markel, H., The history of vaccines and immunization: familiar patterns. New Chall. Health Aff. 24 (2005), 611–621, 10.1377/hlthaff.24.3.611.
3. Czerkinsky, C., Holmgren, J., Vaccines against enteric infections for the developing world. Philos. Trans. Roy. Soc. B: Biol. Sci. 370 (2015), 2–13, 10.1098/rstb.2015.0142.
4. Gebril, A., Alsaadi, M., Acevedo, R., Mullen, A.B., Ferro, V.A., Optimizing efficacy of mucosal vaccines. Expert Rev. Vaccines 11 (2012), 1139–1155, 10.1586/erv.12.81.
5. Chen, X.M., Elisia, I., Kitts, D.D., Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design. J. Pharmacol. Toxicol. Methods 61 (2010), 334–342, 10.1016/j.vascn.2010.02.004.
6. Azizi, A., Kumar, A., Diaz-Mitoma, F., Mestecky, J., Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathog., 6, 2010, e1001147, 10.1371/journal.ppat.1001147.
7. Nochi, T., Takagi, H., Yuki, Y., Yang, L., Masumura, T., Mejima, M., et al. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc. Natl. Acad. Sci. USA 104 (2007), 10986–10991, 10.1073/pnas.0703766104.
8. Yu, M., Vajdy, M., Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes. Expert Opin. Biol. Ther. 10 (2010), 1181–1195, 10.1517/14712598.2010.496776.
9. E. Sjögren, B. Abrahamsson, P. Augustijns, D. Becker, M.B. Bolger, M. Brewster, et al., In vivo methods for drug absorption – comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects, 2014, http://dx.doi.org/10.1016/j.ejps.2014.02.010.
10. Ellis, R.W., Technologies for the design, discovery, formulation and administration of vaccines. Vaccine 19 (2001), 2681–2687, 10.1016/S0264-410X(00)00504-1.
11. Rizwan, S.B., McBurney, W.T., Young, K., Hanley, T., Boyd, B.J., Rades, T., et al. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses. J. Control. Release 165 (2013), 16–21, 10.1016/j.jconrel.2012.10.020.
12. Storni, T., Kündig, T.M., Senti, G., Johansen, P., Immunity in response to particulate antigen-delivery systems. Adv. Drug Deliv. Rev. 57 (2005), 333–355, 10.1016/j.addr.2004.09.008.
13. Bolhassani, A., Safaiyan, S., Rafati, S., Improvement of different vaccine delivery systems for cancer therapy. Mol. Cancer, 10, 2011, 3, 10.1186/1476-4598-10-3.
14. Fujkuyama, Y., Tokuhara, D., Kataoka, K., Gilbert, R.S., McGhee, J.R., Yuki, Y., et al. Novel vaccine development strategies for inducing mucosal immunity. Expert Rev. Vaccines 11 (2012), 367–379, 10.1586/erv.11.196.
15. Mishra, N., Goyal, A.K., Tiwari, S., Paliwal, R., Paliwal, S.R., Vaidya, B., et al. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers. Expert Opin. Ther. Pat. 20 (2010), 661–679, 10.1517/13543771003730425.
16. Lancelot, A., Sierra, T., Serrano, J.L., Nanostructured liquid-crystalline particles for drug delivery. Expert Opin. Drug Deliv. 11 (2014), 547–564, 10.1517/17425247.2014.884556.
17. Leesajakul, W., Nakano, M., Taniguchi, A., Handa, T., Interaction of cubosomes with plasma components resulting in the destabilization of cubosomes in plasma. Colloids Surf. B 34 (2004), 253–258, 10.1016/j.colsurfb.2004.01.010.
18. Rizwan, S.B., Assmus, D., Boehnke, A., Hanley, T., Boyd, B.J., Rades, T., et al. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. Eur. J. Pharm. Biopharm. 79 (2011), 15–22, 10.1016/j.ejpb.2010.12.034.
19. Rizwan, S., Hanley, T., Boyd, B., Rades, T., Hook, S., Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling and release kinetics. J. Pharm. Sci. 98 (2009), 4191–4204, 10.1002/jps.
20. Kim, J., Kim, H., Chung, H., Sohn, Y., Kwon, I., Jeong, S., Drug formulations that form a dispersed cubic phase when mixed with water. Rel. Bioact. Mater. 27 (2000), 1118–1119.
21. Spicer, P.T., Hayden, K.L., Lynch, M.L., Ofori-Boateng, A., Burns, J.L., Novel process for producing cubic liquid crystalline nanoparticles (cubosomes). Langmuir 17 (2001), 5748–5756, 10.1021/la010161w.
22. Spicer, P.T., Small, W.B., Lynch, M.L., Burns, J.L., Dry powder precursors of cubic liquid crystalline nanoparticles (cubosomes). J. Nanopart. Res. 4 (2002), 297–311, 10.1023/A:1021184216308.
23. Avachat, A.M., Parpani, S.S., Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz. Colloids Surf. B 126 (2015), 87–97, 10.1016/j.colsurfb.2014.12.014.
24. Islam, M.A., Firdous, J., Choi, Y.J., Yun, C.H., Cho, C.S., Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review. Int. J. Nanomed. 7 (2012), 6077–6093, 10.2147/IJN.S38330.
25. Nielsen, L.H., Keller, S.S., Boisen, A., Mullertz, A., Rades, T., A slow cooling rate of indomethacin melt spatially confined in microcontainers increases the physical stability of the amorphous drug without influencing its biorelevant dissolution behaviour. Drug Deliv. Transl. Res., 4, 2014, 7.
26. Nielsen, L.H., Keller, S.S., Gordon, K.C., Boisen, A., Rades, T., Mullertz, A., Spatial confinement can lead to increased stability of amorphous indomethacin. Eur. J. Pharm. Biopharm. 81 (2012), 418–425, 10.1016/j.ejpb.2012.03.017.
27. Nielsen, L.H., Melero, A., Keller, S.S., Jacobsen, J., Garrigues, T., Rades, T., et al. Polymeric microcontainers improve oral bioavailability of furosemide. Int. J. Pharm. 504 (2016), 98–109, 10.1016/j.ijpharm.2016.03.050.
28. Ensign, L.M., Cone, R., Hanes, J., Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv. Drug Deliv. Rev. 64 (2012), 557–570, 10.1016/j.addr.2011.12.009.
29. Chirra, H.D., Shao, L., Ciaccio, N., Fox, C.B., Wade, J.M., Ma, A., et al. Planar microdevices for enhanced in vivo retention and oral bioavailability of poorly permeable drugs. Adv. Healthc. Mater. 3 (2014), 1648–1654, 10.1002/adhm.201300676.
30. Randall, C.L., Leong, T.G., Bassik, N., Gracias, D.H., 3D lithographically fabricated nanoliter containers for drug delivery. Adv. Drug Deliv. Rev. 59 (2007), 1547–1561, 10.1016/j.addr.2007.08.024.
31. Ahmed, A., Bonner, C., Desai, T.A., Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery. J. Control. Release 81 (2002), 291–306, 10.1016/s0168-3659(02)00074-3.
32. Tao, S.L., Desai, T.A., Aligned arrays of biodegradable poly(epsilon-caprolactone) nanowires and nanofibers by template synthesis. Nano Lett. 7 (2007), 1463–1468, 10.1021/nl0700346.
33. Nielsen, L.H., Nagstrup, J., Gordon, S., Keller, S.S., Østergaard, J., Rades, T., et al. PH-triggered drug release from biodegradable microwells for oral drug delivery. Biomed. Microdevices 17 (2015), 1–7, 10.1007/s10544-015-9958-5.
34. Petersen, R.S., Keller, S.S., Boisen, A., Hot punching of high-aspect-ratio 3D polymeric microstructures for drug delivery. Lab Chip 15 (2015), 2576–2579, 10.1039/c5lc00372e.
35. Keller, S., Haefliger, D., Boisen, A., Optimized plasma-deposited fluorocarbon coating for dry release and passivation of thin SU-8 cantilevers. J. Vac. Sci. Technol. B: Microelectron. Nanometer Struct., 25, 2007, 1903, 10.1116/1.2806960.
36. Keller, S.S., Bosco, F.G., Boisen, A., Ferromagnetic shadow mask for spray coating of polymer patterns. Microelectron. Eng. 110 (2013), 427–431, 10.1016/j.mee.2013.03.029.
37. Kirby, N.M., Mudie, S.T., Hawley, A.M., Cookson, D.J., Mertens, H.D.T., Cowieson, N., et al. A low-background-intensity focusing small-angle X-ray scattering undulator beamline. J. Appl. Crystallogr. 46 (2013), 1670–1680, 10.1107/S002188981302774X.
38. Ambike, A.A., Mahadik, K.R., Paradkar, A., Stability study of amorphous valdecoxib. Int. J. Pharm. 282 (2004), 151–162, 10.1016/j.ijpharm.2004.06.009.
39. Drummond, C.J., Fong, C., Surfactant self-assembly objects as novel drug delivery vehicles. Curr. Opin. Colloid Interface Sci. 4 (1999), 449–456, 10.1016/S1359-0294(00)00020-0.
40. Bachmann, M.F., Jennings, G.T., Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10 (2010), 787–796, 10.1038/nri2868.
41. Hori, M., Onishi, H., Machida, Y., Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system. Int. J. Pharm. 297 (2005), 223–234, 10.1016/j.ijpharm.2005.04.008.
42. Myschik, J., Eberhardt, F., Rades, T., Hook, S., Immunostimulatory biodegradable implants containing the adjuvant Quil-A – Part I: Physicochemical characterisation. J. Drug Target. 16 (2008), 213–223, 10.1080/10611860701848860.
43. Aomori, H., Ishiguro, T., Kuwata, K., Kaneko, T., Ogino, K., Study on thermal and structural behavior of monoacylglycerol-water systems. II. The phase behavior of monooleoylglycerol-water systems. J. Japan Oil Chem. Soc. 44 (1995), 1004–1011, 10.1017/CBO9781107415324.004.
44. Qiu, H., Ca, M., The phase diagram of the monoolein/water system: metastability and equilibrium aspects. Biomaterials 21 (2000), 223–234.